Smoking cessation

Smoking cessation Letter (2831) Total Article Views Authors: Kaur K, Juneja S, Kaushal S Published Date March 2012 Volume 2012:4 Pages 21 - 22 DOI: http://dx.doi.org/10.2147/CPAA.S30323 Received: 29 January 2012 Accepted: 02 February 2012 Published: 15 March 2012 Kirandeep Kaur, Shivani Juneja, Sandeep Kaushal Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India With reference to the article published under the title "Pharmacologic agents for smoking cessation: A clinical review", we would like to add some information related to smoking cessation therapy among pregnant females. In that article, in the nicotine replacement therapy section, pregnancy has been considered as a contraindication to the use of transdermal patches, gum, lozenges, nasal sprays, and oral inhalers containing nicotine. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: The cognitive impact of anticholinergics: A clinical review Polyphenols as dietary supplements: A double-edged sword Pharmacologic agents for smoking cessation: A clinical review Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response Management of antipsychotic treatment discontinuation and interruptions using model-based simulations Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features